Aardvark Adventures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures

DAVE 208.44

+2.3%

1:47 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ~digs who wrote (2288)	8/3/2006 7:11:33 PM
From: ~digs	Read Replies (1) of 7944

HBIO 4.33 4:44PM Harvard Bioscience beats by $0.02, issues upside Q3 guidance (HBIO) 4.33 -0.05 : HBIO reports Q2 EPS of $0.07 vs $0.05 consensus; revs increase 11.7% YoY to $18.2 mln, above consensus of $17.00 mln . Co issues Q3 guidance, sees EPS of $0.06-0.07 vs $0.06 consensus; sees revs $18.0-19.0 mln vs $17.50 mln consensus. Continued strong market demand for our core products was a major contributor to our results. Infusion pumps and amino acid analyzers were particularly strong this quarter.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next